Chou 2015 Fatty Acid Oxidation O2k-Network Discussion Forum: Difference between revisions

From Bioblast
No edit summary
No edit summary
Line 7: Line 7:
|abstract='''Protocol''': final concentration of digitonin in chamber is 10Ξg/ml
|abstract='''Protocol''': final concentration of digitonin in chamber is 10Ξg/ml
cell number in chamber is 2 millions cell/ml, cell type PBMC, Malate (2mM), Palmitoyl-DLcarnitine-HCl (20ΞM), ADP (2.5mM), pyruvate (5mM), glutamate (10mM), succinate (10mM), rotenone (0.1ΞM), malonic acid(5mM), myxothiazol (0.5ΞM), antimycin A (2.5ΞM), TMPD (0.5mM), azide (100mM)
cell number in chamber is 2 millions cell/ml, cell type PBMC, Malate (2mM), Palmitoyl-DLcarnitine-HCl (20ΞM), ADP (2.5mM), pyruvate (5mM), glutamate (10mM), succinate (10mM), rotenone (0.1ΞM), malonic acid(5mM), myxothiazol (0.5ΞM), antimycin A (2.5ΞM), TMPD (0.5mM), azide (100mM)
|keywords=PBMC
}}
}}
{{Labeling
{{Labeling

Revision as of 08:10, 25 October 2016

Chou 2015 Fatty Acid Oxidation O2k-Network Discussion Forum

Link: O2k-Network Discussion Forum

Chou Cheng-Hsien (2015)

Event: Fatty Acid Oxidation O2k-Network Discussion Forum

Protocol: final concentration of digitonin in chamber is 10Ξg/ml cell number in chamber is 2 millions cell/ml, cell type PBMC, Malate (2mM), Palmitoyl-DLcarnitine-HCl (20ΞM), ADP (2.5mM), pyruvate (5mM), glutamate (10mM), succinate (10mM), rotenone (0.1ΞM), malonic acid(5mM), myxothiazol (0.5ΞM), antimycin A (2.5ΞM), TMPD (0.5mM), azide (100mM)

â€Ē Keywords: PBMC


Labels:


Tissue;cell: Blood cells  Preparation: Permeabilized cells, Permeabilized tissue 


Coupling state: OXPHOS, ETS"ETS" is not in the list (LEAK, ROUTINE, OXPHOS, ET) of allowed values for the "Coupling states" property. 


Palmitoylcarnitine 

Cookies help us deliver our services. By using our services, you agree to our use of cookies.